MedPath
HSA Approval

VIVIDRIN EYE DROPS 20 mg/ml

SIN04854P

VIVIDRIN EYE DROPS 20 mg/ml

VIVIDRIN EYE DROPS 20 mg/ml

June 28, 1990

BAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED

BAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED
Licence HolderBAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

SOLUTION

OPHTHALMIC

Medical Information

S01GX01

cromoglicic acid

Manufacturer Information

BAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED

DR GERHARD MANN CHEM-PHARM FABRIK GMBH

Active Ingredients

DISODIUM CROMOGLYCATE

20 mg/ml

Cromoglicic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VIVIDRIN EYE DROPS 20 mg/ml - HSA Approval | MedPath